SE9501782D0 - Method of predicting the therapeutic response of a drug against a malignant tumour - Google Patents
Method of predicting the therapeutic response of a drug against a malignant tumourInfo
- Publication number
- SE9501782D0 SE9501782D0 SE9501782A SE9501782A SE9501782D0 SE 9501782 D0 SE9501782 D0 SE 9501782D0 SE 9501782 A SE9501782 A SE 9501782A SE 9501782 A SE9501782 A SE 9501782A SE 9501782 D0 SE9501782 D0 SE 9501782D0
- Authority
- SE
- Sweden
- Prior art keywords
- tumour
- cells
- therapeutic response
- sample
- pct
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56966—Animal cells
- G01N33/56972—White blood cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Cell Biology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Virology (AREA)
- Physiology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Priority Applications (12)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9501782A SE9501782D0 (sv) | 1995-05-12 | 1995-05-12 | Method of predicting the therapeutic response of a drug against a malignant tumour |
EP96919762A EP0824696B1 (en) | 1995-05-12 | 1996-05-10 | Method and kit for predicting the therapeutic response of a drug against a malignant tumour |
JP8533784A JPH11504715A (ja) | 1995-05-12 | 1996-05-10 | 悪性腫瘍に対する薬の治療応答を予測するための方法及びキット |
AT96919762T ATE196688T1 (de) | 1995-05-12 | 1996-05-10 | Verfahren zur vorhersage der therapeutischen antwort eines medikamentes auf einen malignen tumoren |
PCT/EP1996/002007 WO1996035949A1 (en) | 1995-05-12 | 1996-05-10 | Method and kit for predicting the therapeutic response of a drug against a malignant tumour |
ES96919762T ES2151665T3 (es) | 1995-05-12 | 1996-05-10 | Procedimiento y equipo para predecir la respuesta terapeutica de un farmaco contra un tumor maligno. |
DK96919762T DK0824696T3 (da) | 1995-05-12 | 1996-05-10 | Fremgangsmåde og kit til at forudsige den terapeutiske reaktion på et medikament mod en malign tumor |
PT96919762T PT824696E (pt) | 1995-05-12 | 1996-05-10 | Processo e kit para a previsao da resposta terapeutica duma droga usada contra um tumor maligno |
US08/952,140 US6114128A (en) | 1995-05-12 | 1996-05-10 | Method and kit for predicting the therapeutic response of a drug against a malignant tumor |
DE69610496T DE69610496T2 (de) | 1995-05-12 | 1996-05-10 | Verfahren zur vorhersage der therapeutischen antwort eines medikamentes auf einen malignen tumoren |
CA002215627A CA2215627A1 (en) | 1995-05-12 | 1996-05-10 | Method and kit for predicting the therapeutic response of a drug against a malignant tumour |
GR20000402580T GR3034891T3 (en) | 1995-05-12 | 2000-11-22 | Method and kit for predicting the therapeutic response of a drug against a malignant tumour |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9501782A SE9501782D0 (sv) | 1995-05-12 | 1995-05-12 | Method of predicting the therapeutic response of a drug against a malignant tumour |
Publications (1)
Publication Number | Publication Date |
---|---|
SE9501782D0 true SE9501782D0 (sv) | 1995-05-12 |
Family
ID=20398299
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE9501782A SE9501782D0 (sv) | 1995-05-12 | 1995-05-12 | Method of predicting the therapeutic response of a drug against a malignant tumour |
Country Status (12)
Country | Link |
---|---|
US (1) | US6114128A (sv) |
EP (1) | EP0824696B1 (sv) |
JP (1) | JPH11504715A (sv) |
AT (1) | ATE196688T1 (sv) |
CA (1) | CA2215627A1 (sv) |
DE (1) | DE69610496T2 (sv) |
DK (1) | DK0824696T3 (sv) |
ES (1) | ES2151665T3 (sv) |
GR (1) | GR3034891T3 (sv) |
PT (1) | PT824696E (sv) |
SE (1) | SE9501782D0 (sv) |
WO (1) | WO1996035949A1 (sv) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6087090A (en) * | 1997-02-25 | 2000-07-11 | Celtrix Pharmaceuticals, Inc. | Methods for predicting drug response |
US5824467A (en) * | 1997-02-25 | 1998-10-20 | Celtrix Pharmaceuticals | Methods for predicting drug response |
US20030096237A1 (en) * | 2000-08-28 | 2003-05-22 | Ulrich Certa | Determination of the ability of patients to respond to a tumor treatment |
SE0402536D0 (sv) | 2004-10-20 | 2004-10-20 | Therim Diagnostica Ab | Immunoregulation in cancer, chronic inflammatory and autoimmune diseases |
AU2010309921B2 (en) | 2009-10-19 | 2017-04-13 | Cvie Therapeutics Limited | Methods and systems for pharmacogenomic treatment of cardiovascular conditions |
WO2012024236A1 (en) * | 2010-08-14 | 2012-02-23 | Biogen Idec Ma Inc. | LTβR BLOCKADE: METHODS FOR OPTIMIZING THERAPEUTIC RESPONSIVENESS OF PATIENTS |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5426029A (en) * | 1986-03-31 | 1995-06-20 | T Cell Diagnostics, Inc. | Therapeutic and diagnostic methods using leukocyte surface antigens |
CA1296622C (en) * | 1986-08-12 | 1992-03-03 | Jeffrey E. Anderson | Method and apparatus for automated assessment of the immunoregulatory status of the mononuclear leukocyte immune system |
-
1995
- 1995-05-12 SE SE9501782A patent/SE9501782D0/sv unknown
-
1996
- 1996-05-10 JP JP8533784A patent/JPH11504715A/ja not_active Ceased
- 1996-05-10 CA CA002215627A patent/CA2215627A1/en not_active Abandoned
- 1996-05-10 US US08/952,140 patent/US6114128A/en not_active Expired - Fee Related
- 1996-05-10 DK DK96919762T patent/DK0824696T3/da active
- 1996-05-10 AT AT96919762T patent/ATE196688T1/de not_active IP Right Cessation
- 1996-05-10 PT PT96919762T patent/PT824696E/pt unknown
- 1996-05-10 DE DE69610496T patent/DE69610496T2/de not_active Expired - Fee Related
- 1996-05-10 ES ES96919762T patent/ES2151665T3/es not_active Expired - Lifetime
- 1996-05-10 WO PCT/EP1996/002007 patent/WO1996035949A1/en active IP Right Grant
- 1996-05-10 EP EP96919762A patent/EP0824696B1/en not_active Expired - Lifetime
-
2000
- 2000-11-22 GR GR20000402580T patent/GR3034891T3/el not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
PT824696E (pt) | 2001-03-30 |
DK0824696T3 (da) | 2001-01-02 |
GR3034891T3 (en) | 2001-02-28 |
DE69610496D1 (de) | 2000-11-02 |
DE69610496T2 (de) | 2001-05-10 |
ES2151665T3 (es) | 2001-01-01 |
EP0824696A1 (en) | 1998-02-25 |
CA2215627A1 (en) | 1996-11-14 |
EP0824696B1 (en) | 2000-09-27 |
US6114128A (en) | 2000-09-05 |
ATE196688T1 (de) | 2000-10-15 |
JPH11504715A (ja) | 1999-04-27 |
WO1996035949A1 (en) | 1996-11-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Shin et al. | Monocytoid B-cell lymphoma in patients with Sjögren's syndrome: a clinicopathologic study of 13 patients | |
BR9917218A (pt) | Anticorpos monoclonais, antìgenos, e diagnósticoe terapia de doenças malignas | |
EP0852004A2 (en) | MULTIPLEXED ANALYSIS OF CLINICAL SPECIMENS | |
DE69735294D1 (de) | Spezifische monoklonale antikörperfür die extrazelluläre domäne von protasta-spezifischem membranantigen | |
MX9801687A (es) | Compuestos y metodos para el diagnostico de tuberculosis. | |
Bentley et al. | Synthesis of factors D, B and P of the alternative pathway of complement activation, as well as of C3, by guinea-pig peritoneal macrophages in vitro | |
CA1305928C (en) | Monoclonal antibody specific to a novel epitope of the lfa-1 antigen of human t lymphocytes | |
DE69841164D1 (de) | Sphingosin-1-phosphat-lyase polypeptide, polynukleotide und modulierende mitteln, und verfahren zu deren verwendung | |
DK0559795T3 (da) | Fremgangsmåder til diagnosticering af kroniske smerter i lænderegionen og halshvrivelsøjlen | |
AU7260496A (en) | A method and diagnostic test kit for use in aiding the diagnosis of fibromyyalgia and chronic fatigue syndrome (CFS) | |
SE9500023D0 (sv) | Method of detecting cancer | |
Bloom et al. | In vitro methods in cell-mediated immunity: a progress report | |
PL309637A1 (en) | Diagnostic test and therapy for demyelination diseases such as multiple sclerosis | |
SE9501782D0 (sv) | Method of predicting the therapeutic response of a drug against a malignant tumour | |
AU6828387A (en) | Assay for human breast cancer | |
ATE126599T1 (de) | Verfahren zur bestimmung von anti-rns- antikörpern. | |
DE69839876D1 (de) | Prostat-spezifisches-antigenformen und verfahren zu ihrer bestimmung | |
Armitage et al. | Normal and certain leukaemic B cells express IL-2 receptors without in vitro activation. | |
Emmitt et al. | Crossed immunoelectrophoresis: qualitative and quantitative considerations | |
Nicolson et al. | Growth of rat mammary adenocarcinoma cells in semisolid clonogenic medium not correlated with spontaneous metastatic behavior: heterogeneity in the metastatic, antigenic, enzymatic, and drug sensitivity properties of cells from different sized colonies | |
OA08331A (fr) | Anticorps monoclonaux, lignées de cellules et trousses les contenant pour diagnostiquer les épithéliomas de poumons humains ne comportant pas de petites cellules; | |
GB9503406D0 (en) | Detection of antibody production | |
DE69619667D1 (de) | Überwachung der immunotherapie von malignen tumoren | |
Bean et al. | Factors That Affect the Results of Microcytotoxicity Testing in Man 1, 2, 3 | |
GODFREY et al. | SOME RECENT THESES ON THE THYMUS AND RELATED TOPICS |